Synchronous BRAF<sup>V600E</sup> and MEK inhibition leads to superior control of murine melanoma by limiting MEK inhibitor induced skin toxicity

Jules Gadiot; Anna I Hooijkaas; Marcel A Deken; Christian U Blank

doi:10.2147/OTT.S52552

open access to scientific and medical research

Back to Journals » OncoTargets and Therapy » Volume 6

Original Research

Synchronous BRAF^V600E and MEK inhibition leads to superior control of murine melanoma by limiting MEK inhibitor induced skin toxicity

Total article views		HTML views	PDF downloads	Totals
9,160	Dovepress*	7,603+	1,416	9,019
	PubMed Central*	1,557	358	1,915
	Totals	9,160	1,774	10,934
*Since 28 November 2013 +Since July 2016

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.

Synchronous BRAFV600E and MEK inhibition leads to superior control of murine melanoma by limiting MEK inhibitor induced skin toxicity

Synchronous BRAF^V600E and MEK inhibition leads to superior control of murine melanoma by limiting MEK inhibitor induced skin toxicity